EB-3D

(5E)-5-[(2E)-2-[1-[1-[3-(2-hydroxypropan-2-yl)phenoxy]propan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

EB 47, PARP-1 inhibitor

methyl 4-(4-tert-butylphenyl)-6-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate

EB-42486

Amitifadine

PARP Inhibitor IX, EB-47

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-({[4-(Propan-2-yl)phenyl]amino}methyl)cyclohexan-1-ol

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(1-Methoxy-3,5-dimethylcyclohexyl)methanamine

(4-Methyl-tetrahydro-furan-2-yl)-methanol

6-Methyl-2-(thiophen-2-yl)pyrimidine-4-carboxylic acid

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde